Pfizer Terminates Biometrics Services Contract With India’s Siro Clinpharm
This article was originally published in PharmAsia News
Executive SummaryMUMBAI - Pfizer has terminated its clinical data management and biometrics services contract with India's Siro Clinpharm as part of its "global strategy to reduce the number of biometric suppliers." Siro Clinpharm is one of the largest and most established players in the Indian clinical research industry
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).